Pegasys Approved for Personalised Hepatitis C Therapy

Posted on July 21, 2008 
Filed Under Interferon, Virology

Pegasys (peginterferon alfa-2a) maintained its leadership of the global pegylated interferon market and continued to gain market share worldwide. While the overall sales increase in the first half-year was modest, strong growth in Japan and strong gains in the Asia helped offset continued market volume declines in the United States and Western Europe.
In June the EU authorities approved a shortened course of treatment with Pegasys plus Copegus (ribavirin) for patients with genotype 2 or 3 hepatitis C virus infection who have low virus levels and show a rapid virological response. The approval personalises therapy for these patients, offering a chance for cure with only four months’ treatment. This new approach is made possible by Roche Diagnostics’ highly sensitive, real-time cobas PCR diagnostic tests.

Comments

2 Responses to “Pegasys Approved for Personalised Hepatitis C Therapy”

  1. JEREMY on July 4th, 2010 5:18 am


    PillSpot.org. Canadian Health&Care.Best quality drugs.No prescription online pharmacy.Special Internet Prices. High quality pills. Order drugs online…

    Buy:Lasix.Aricept.Zetia.Acomplia.SleepWell.Ventolin.Wellbutrin SR.Zocor.Advair.Benicar.Female Cialis.Female Pink Viagra.Lipitor.Amoxicillin.Buspar.Seroquel.Prozac.Cozaar.Nymphomax.Lipothin….

  2. ROSS on July 15th, 2010 6:14 pm


    Pillspot.org. Canadian Health&Care.Special Internet Prices.No prescription online pharmacy.Best quality drugs. No prescription pills. Buy pills online…

    Buy:Female Cialis.Nymphomax.Cozaar.Benicar.Acomplia.Aricept.Lipitor.Amoxicillin.Lipothin.Zocor.Zetia.Prozac.Seroquel.Female Pink Viagra.Ventolin.Wellbutrin SR.Lasix.Buspar.SleepWell.Advair….

Leave a Reply

You must be logged in to post a comment.